Incidence and risk of infections in renal cell cancer (RCC) and non-RCC patients treated with everolimus and temsirolimus: A meta-analysis of randomized control trials.
Marina Kaymakcalan
No relevant relationships to disclose
Youjin Je
No relevant relationships to disclose
Guru Sonpavde
Consultant or Advisory Role - Novartis; Pfizer
Honoraria - Novartis
Matt D. Galsky
No relevant relationships to disclose
Paul Linh Nguyen
No relevant relationships to disclose
Fabio Schutz
No relevant relationships to disclose
Daniel Yick Chin Heng
Consultant or Advisory Role - Bayer/Onyx; Novartis; Pfizer
Christopher J. Richards
No relevant relationships to disclose
Toni K. Choueiri
Consultant or Advisory Role - AVEO; Bayer/Onyx; Genentech; GlaxoSmithKline; Novartis; Pfizer